Redefining Medicine with special guest Dr. Dave Rabin

Summary

Dr. Jeff, Chief Medical Officer at Fullscript, introduces a cutting-edge supplement course designed to aid healthcare providers in making informed clinical decisions. Dr. Erica Schwarz interviews Dr. David Ran, a psychiatrist and expert in psychedelic medicine, who discusses the potential of psychedelic-assisted therapy for treating PTSD and addiction. They explore the importance of combining therapy with medicines like ketamine to promote healing and discuss the development of Apollo, a wearable technology designed to enhance safety pathways in the nervous system.

Takeaways

• 🌐 Dr. Jeff Glad is the Chief Medical Officer at Fullscript, a leading healthcare platform for providers.
• 📚 Fullscript offers a cutting-edge supplement course in collaboration with A4M and industry experts.
• 🕒 The A4M supplement certification course consists of 16 hours of content designed to inform clinical decisions.
• 💊 The course aims to provide clinical context for confidently recommending supplements to patients.
• 🎓 Use the promo code 'podcast2' at checkout on www.m.com to get a 20% discount on the course.
• 👩‍⚕️ Dr. Erica Schwarz is a distinguished faculty member in disciplines like hormone therapy and IV nutritional support.
• 💊 Dr. David Ran is a psychiatrist and neuroscientist specializing in psychedelic medicine.
• 🌿 Dr. Ran explores natural techniques and psychedelic-assisted therapy for treating addiction and PTSD.
• 📈 MDMA-assisted therapy has shown tremendous results in Phase 2 trials with the FDA.
• 🔄 Dr. Ran runs a training clinic to address the shortage of professionals trained in psychedelic therapy.
• 🏥 Dr. Ran's practice operates remotely, increasing access to care, especially for ketamine therapy.
• 🧪 The wearable technology Apollo was developed to activate safety pathways in the body, similar to the effects of psychedelic medicines.

Q & A

What is Fullscript and what does it offer to healthcare providers?

Fullscript is a leading healthcare platform that allows providers to prescribe supplements, helping to drive better patient outcomes and scale practice growth with high efficiency.

What is the A4M supplement certification course mentioned in the script?

The A4M supplement certification course is a 16-hour content program designed to provide clinical context for healthcare providers to confidently recommend supplements to their patients.

What is the promo code offered for the A4M supplement certification course?

The promo code offered for the A4M supplement certification course is 'podcast2', which provides a 20% discount at checkout.

What is the focus of the 'Redefining Medicine' program?

The 'Redefining Medicine' program focuses on Physicians and practitioners who are redefining medicine through integrative, functional, and holistic approaches to health and well-being.

Who is Dr. David Ran and what is his expertise?

Dr. David Ran is a psychiatrist and an expert in psychedelics, serving as a bridge between conventional medicine and the emerging field of psychedelic therapy.

What is the significance of the MDMA-assisted therapy trials mentioned in the script?

The MDMA-assisted therapy trials are significant because they have shown tremendous results, some of the best ever seen in psychiatry, particularly for treating PTSD.

How does Dr. Ren approach the treatment of patients with addiction and PTSD?

Dr. Ren explores various techniques, including natural methods like soothing touch and music, as well as psychedelic-assisted therapy, to treat patients with addiction and PTSD.

What is the role of the training clinic that Dr. Ren runs?

The training clinic run by Dr. Ren mentors junior clinicians in psychedelic therapy, aiming to address the shortage of professionals trained in this field.

How does remote work in ketamine therapy increase access to care?

Remote work in ketamine therapy allows patients to receive the medication at home and participate in therapy sessions over platforms like Zoom, making the treatment more accessible.

What is the interaction between SSRIs and psychedelics, and how does it affect treatment?

SSRIs and psychedelics can have negative interactions, potentially blunting the effects of psychedelics or causing serotonin syndrome. Patients often need to taper off SSRIs before undergoing psychedelic therapy.

What is the difference between the use of SSRIs and psychedelic medicines according to the script?

SSRIs are used to stabilize patients by numbing negative thoughts and emotions, whereas psychedelic medicines are used to facilitate high-intensity experiences that allow patients to confront and address their emotions with the help of therapy.

What is Apollo Neuroscience and how does it relate to the work discussed in the script?

Apollo Neuroscience is a wearable technology developed to induce a sense of safety in the body, similar to the effects of psychedelic medicines. It uses gentle vibrations to activate neural pathways associated with safety and emotional well-being.